About NanoString Technologies (NASDAQ:NSTG)
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.
Industry, Sector and Symbol
Industry MED PRODS
Trailing P/E Ratio-3.52688172043011
Forward P/E Ratio-2.35
Sales & Book Value
Annual Sales$114.90 million
Price / Sales1.45
Price / CashN/A
Book Value$1.58 per share
Price / Book4.15
Return on Equity-129.90%
Return on Assets-32.06%
NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions
What is NanoString Technologies' stock symbol?
NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."
How were NanoString Technologies' earnings last quarter?
NanoString Technologies Inc (NASDAQ:NSTG) posted its earnings results on Wednesday, March, 7th. The biotechnology company reported ($0.34) EPS for the quarter, beating the Zacks' consensus estimate of ($0.42) by $0.08. The biotechnology company had revenue of $35.20 million for the quarter, compared to the consensus estimate of $31.57 million. NanoString Technologies had a negative return on equity of 129.90% and a negative net margin of 37.91%. The company's revenue for the quarter was up 39.7% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.55) earnings per share. View NanoString Technologies' Earnings History.
What guidance has NanoString Technologies issued on next quarter's earnings?
NanoString Technologies updated its FY18 earnings guidance on Wednesday, March, 7th. The company provided earnings per share (EPS) guidance of (2.90)-($2.60) for the period, compared to the Thomson Reuters consensus EPS estimate of ($2.48).
Where is NanoString Technologies' stock going? Where will NanoString Technologies' stock price be in 2018?
4 brokers have issued twelve-month target prices for NanoString Technologies' stock. Their forecasts range from $12.00 to $20.00. On average, they anticipate NanoString Technologies' share price to reach $14.67 in the next year. View Analyst Ratings for NanoString Technologies.
Who are some of NanoString Technologies' key competitors?
Some companies that are related to NanoString Technologies include Pacific Biosciences of California (PACB), RTI Surgical (RTIX), GenMark Diagnostics (GNMK), Rockwell Medical (RMTI), Evolus (EOLS), Quotient (QTNT), Chimerix (CMRX), Fluidigm (FLDM), Pulse Biosciences (PLSE), T2 Biosystems (TTOO), Cogentix Medical (CGNT), Cytosorbents (CTSO), Aceto (ACET), Orthopediatrics (KIDS), Restoration Robotics (HAIR), Veracyte (VCYT), Helius Medical Technologies (HSDT) and Sientra (SIEN).
Who are NanoString Technologies' key executives?
NanoString Technologies' management team includes the folowing people:
- William D. Young, Independent Chairman of the Board (Age 72)
- R. Bradley Gray, President, Chief Executive Officer, Director (Age 40)
- K. Thomas Bailey, Chief Financial Officer, Treasurer (Age 50)
- J. Chad Brown, Senior Vice President - Sales and Marketing
- Mary Tedd Allen, Senior Vice President - Operations (Age 54)
- Joseph M. Beechem Ph.D., Senior Vice President - Research and Development (Age 59)
- David W. Ghesquiere, Senior Vice President - Corporate & Business Development (Age 50)
- Elisha W. Finney, Director (Age 55)
- Nicholas G. Galakatos Ph.D., Independent Director (Age 59)
- Robert M. Hershberg M.D. Ph.D., Independent Director (Age 51)
Has NanoString Technologies been receiving favorable news coverage?
Headlines about NSTG stock have been trending somewhat positive on Saturday, according to Accern. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. NanoString Technologies earned a media sentiment score of 0.14 on Accern's scale. They also gave news stories about the biotechnology company an impact score of 46.08 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are NanoString Technologies' major shareholders?
NanoString Technologies' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.25%), Levin Capital Strategies L.P. (5.02%), ARK Investment Management LLC (4.49%), Millennium Management LLC (3.96%), Altrinsic Global Advisors LLC (1.90%) and Renaissance Technologies LLC (0.76%). Company insiders that own NanoString Technologies stock include Barney Saunders, Charles P Waite Jr, David W Ghesquiere, James A Johnson, R Bradley Gray, Wayne Burns and William Young. View Institutional Ownership Trends for NanoString Technologies.
Which major investors are selling NanoString Technologies stock?
NSTG stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Spark Investment Management LLC, Renaissance Technologies LLC, Algert Global LLC, Tekla Capital Management LLC, TIAA CREF Investment Management LLC, Candriam Luxembourg S.C.A. and Millennium Management LLC. Company insiders that have sold NanoString Technologies company stock in the last year include David W Ghesquiere and R Bradley Gray. View Insider Buying and Selling for NanoString Technologies.
Which major investors are buying NanoString Technologies stock?
NSTG stock was bought by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Levin Capital Strategies L.P., Altrinsic Global Advisors LLC, Broadfin Capital LLC, Alambic Investment Management L.P., Two Sigma Investments LP, Deutsche Bank AG and Baird Financial Group Inc.. View Insider Buying and Selling for NanoString Technologies.
How do I buy shares of NanoString Technologies?
Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is NanoString Technologies' stock price today?
One share of NSTG stock can currently be purchased for approximately $6.56.
How big of a company is NanoString Technologies?
NanoString Technologies has a market capitalization of $166.63 million and generates $114.90 million in revenue each year. The biotechnology company earns $-43,560,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis. NanoString Technologies employs 467 workers across the globe.
How can I contact NanoString Technologies?
NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]
MarketBeat Community Rating for NanoString Technologies (NSTG)MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
NanoString Technologies (NASDAQ:NSTG) Earnings History and Estimates Chart
NanoString Technologies (NASDAQ NSTG) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/7/2018||Q4 2017||($0.42)||($0.34)||$31.57 million||$35.20 million||View||Listen|
|11/2/2017||Q3 2017||($0.56)||($0.45)||$26.27 million||$27.02 million||View||N/A|
|8/8/2017||Q2 2017||($0.37)||($0.20)||$29.87 million||$34.59 million||View||Listen|
|5/4/2017||Q1 2017||($0.87)||($0.87)||$17.53 million||$18.10 million||View||Listen|
|3/1/2017||Q4 2016||($0.52)||($0.55)||$24.90 million||$25.23 million||View||Listen|
|11/2/2016||Q316||($0.52)||($0.51)||$23.46 million||$23.90 million||View||N/A|
|8/3/2016||Q2||($0.66)||($0.55)||$19.62 million||$22.60 million||View||N/A|
|5/5/2016||Q1||($0.69)||($0.74)||$14.92 million||$14.70 million||View||N/A|
|2/29/2016||Q4||($0.54)||($0.44)||$21.12 million||$22.30 million||View||N/A|
|11/2/2015||Q315||($0.50)||($0.49)||$15.44 million||$15.70 million||View||Listen|
|8/4/2015||Q215||($0.57)||($0.66)||$12.80 million||$13.10 million||View||N/A|
|5/6/2015||Q115||($0.58)||($0.81)||$12.10 million||$11.59 million||View||N/A|
|2/24/2015||Q4 2014||($0.60)||$15.55 million||$14.22 million||View||N/A|
|11/4/2014||Q314||($0.56)||($0.54)||$11.80 million||$12.30 million||View||N/A|
|8/5/2014||Q214||($0.71)||($0.58)||$10.20 million||$10.90 million||View||N/A|
|5/7/2014||Q114||($0.70)||($0.56)||$8.37 million||$8.70 million||View||N/A|
|2/26/2014||Q4||($0.89)||($0.60)||$9.61 million||$10.10 million||View||N/A|
|11/5/2013||Q3 2013||($0.67)||($0.53)||$7.67 million||$8.39 million||View||N/A|
|8/6/2013||Q2 2013||($0.78)||($0.67)||$6.80 million||$7.22 million||View||N/A|
NanoString Technologies (NASDAQ:NSTG) Earnings Estimates
Current Year EPS Consensus Estimate: $-2.79 EPS
Next Year EPS Consensus Estimate: $-2.17 EPS
Dividend History for NanoString Technologies (NASDAQ:NSTG)
No dividend announcements for this company have been tracked by MarketBeat.com
NanoString Technologies (NASDAQ NSTG) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 24.40%
Institutional Ownership Percentage: 91.96%
NanoString Technologies (NASDAQ NSTG) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/13/2018||William Young||Director||Buy||30,000||$6.91||$207,300.00||30,000|| |
|11/13/2017||David W Ghesquiere||SVP||Sell||689||$8.14||$5,608.46||17,327|| |
|4/3/2017||R Bradley Gray||Insider||Sell||1,100||$20.58||$22,638.00||75,785|| |
|12/6/2016||Wayne Burns||SVP||Sell||21,666||$22.04||$477,518.64||71,034|| |
|11/21/2016||Charles P Waite Jr||Director||Sell||588,024||$21.25||$12,495,510.00||1,707|| |
|11/11/2016||Barney Saunders||SVP||Sell||11,983||$22.48||$269,377.84||6,371|| |
|11/11/2016||James A Johnson||CFO||Sell||10,000||$22.57||$225,700.00||10,698|| |
|11/11/2016||R Bradley Gray||Insider||Sell||37,325||$22.49||$839,439.25||79,428|| |
|10/26/2016||Charles P Waite Jr||Director||Sell||42,489||$20.56||$873,573.84||1,707|| |
|9/8/2016||Charles P Waite Jr||Director||Sell||29,105||$16.51||$480,523.55||1,707|| |
|9/7/2016||Wayne Burns||SVP||Sell||3,961||$16.50||$65,356.50||59,704|| |
|8/30/2016||Charles P Waite Jr||Director||Sell||111,060||$16.57||$1,840,264.20||1,707|| |
|8/25/2016||Charles P Waite Jr||Director||Sell||40,363||$16.59||$669,622.17||1,707|| |
|8/22/2016||Charles P Waite Jr||Director||Sell||72,145||$16.61||$1,198,328.45||1,707|| |
|8/16/2016||Charles P Waite Jr||Director||Sell||257,698||$16.55||$4,264,901.90||1,707|| |
|3/2/2016||David W Ghesquiere||SVP||Sell||1,321||$14.86||$19,630.06||2,521|| |
|8/13/2015||Wayne Burns||SVP||Sell||30,000||$14.93||$447,900.00|| |
|12/2/2014||Barney Saunders||SVP||Sell||30,000||$14.93||$447,900.00|| |
|11/14/2014||Charles P Waite Jr||Director||Sell||14,632||$12.25||$179,242.00|| |
|9/8/2014||Charles P Waite Jr||Director||Sell||45,000||$11.21||$504,450.00|| |
|9/5/2014||Charles P Waite Jr||Director||Sell||86,942||$11.17||$971,142.14|| |
|9/3/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||35,000||$11.15||$390,250.00|| |
|8/19/2014||Charles P Waite Jr||Director||Sell||1,700||$12.01||$20,417.00|| |
|8/19/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||20,257||$12.05||$244,096.85|| |
|8/18/2014||Charles P Waite Jr||Director||Sell||18,557||$12.05||$223,611.85|| |
|8/18/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||11,925||$12.05||$143,696.25|| |
|8/15/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||28,801||$12.36||$355,980.36|| |
|6/13/2014||Charles P Waite Jr||Director||Sell||166,755||$15.08||$2,514,665.40|| |
|6/13/2014||Wayne Burns||SVP||Sell||4,900||$15.01||$73,549.00|| |
|6/12/2014||Barney Saunders||SVP||Sell||28,000||$15.04||$421,120.00|| |
|6/10/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||160,000||$15.48||$2,476,800.00|| |
|6/9/2014||Wayne Burns||SVP||Sell||20,100||$15.76||$316,776.00|| |
|7/1/2013||Lifesciences Ii L.P. Clarus||Major Shareholder||Buy||750,000||$10.00||$7,500,000.00|| |
NanoString Technologies (NASDAQ NSTG) News Headlines
|Zacks: Analysts Expect NanoString Technologies Inc (NSTG) Will Announce Quarterly Sales of $21.90 Million|
www.americanbankingnews.com - March 20 at 7:52 AM
|Edited Transcript of NSTG earnings conference call or presentation 7-Mar-18 9:30pm GMT|
finance.yahoo.com - March 18 at 8:12 AM
|NanoString Technologies Inc (NSTG) Director William Young Acquires 30,000 Shares|
www.americanbankingnews.com - March 14 at 7:49 PM
|NanoString Technologies Inc (NSTG) Receives Average Rating of "Hold" from Brokerages|
www.americanbankingnews.com - March 11 at 10:52 AM
|Morgan Stanley Trims NanoString Technologies (NSTG) Target Price to $12.00|
www.americanbankingnews.com - March 8 at 6:41 PM
|NanoString Technologies (NSTG) Issues Earnings Results, Beats Estimates By $0.08 EPS|
www.americanbankingnews.com - March 8 at 10:29 AM
|NanoString Technologies Releases Fourth Quarter and Full Year 2017 Operating Results and Provides 2018 Outlook|
finance.yahoo.com - March 7 at 6:40 PM
|NanoString Technologies (NSTG) Issues FY18 Earnings Guidance|
www.americanbankingnews.com - March 7 at 5:21 PM
|Should You Buy NanoString Technologies Inc (NASDAQ:NSTG) At $6.49?|
finance.yahoo.com - March 7 at 8:11 AM
|NanoString to Present at the 38th Annual Cowen Healthcare Conference|
finance.yahoo.com - March 6 at 5:45 PM
|Spark Investment Management LLC Sells 178,300 Shares of NanoString Technologies Inc (NSTG)|
www.americanbankingnews.com - March 3 at 12:36 PM
|Zacks: Brokerages Anticipate NanoString Technologies Inc (NSTG) Will Announce Quarterly Sales of $30.32 Million|
www.americanbankingnews.com - March 3 at 12:04 PM
|Altrinsic Global Advisors LLC Buys 170,000 Shares of NanoString Technologies Inc (NSTG)|
www.americanbankingnews.com - March 2 at 4:10 AM
|NanoString Technologies (NSTG) Set to Announce Quarterly Earnings on Wednesday|
www.americanbankingnews.com - February 28 at 3:14 AM
|ARK Investment Management LLC Has $8.51 Million Stake in NanoString Technologies Inc (NSTG)|
www.americanbankingnews.com - February 26 at 5:08 AM
|NanoString Technologies to Release Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call on Wednesday, March 7, 2018|
finance.yahoo.com - February 21 at 8:15 AM
|NanoString Technologies (NSTG) Scheduled to Post Quarterly Earnings on Tuesday|
www.americanbankingnews.com - February 20 at 4:14 AM
|NanoString Technologies Inc (NSTG) Given Average Rating of "Hold" by Analysts|
www.americanbankingnews.com - February 14 at 11:06 AM
|NanoString Technologies Inc (NSTG) Expected to Announce Quarterly Sales of $30.32 Million|
www.americanbankingnews.com - February 14 at 5:06 AM
|NanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) Conference|
finance.yahoo.com - February 12 at 9:06 AM
|NanoString Technologies (NSTG) Says Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology|
www.streetinsider.com - February 7 at 8:51 AM
|NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology|
finance.yahoo.com - February 6 at 8:49 AM
|NanoString Technologies (NSTG) Lowered to Strong Sell at ValuEngine|
www.americanbankingnews.com - February 4 at 7:40 PM
|Zacks: Analysts Expect NanoString Technologies Inc (NSTG) Will Post Earnings of -$0.43 Per Share|
www.americanbankingnews.com - January 26 at 1:24 PM
|New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America — Factors of Influence, Major Initiatives and Sustained Production|
finance.yahoo.com - January 26 at 8:37 AM
|NanoString Reports Inducement Grant Under NASDAQ Listing Rules|
finance.yahoo.com - January 20 at 9:31 AM
|NanoString Appoints Thomas Bailey as Chief Financial Officer|
finance.yahoo.com - January 16 at 9:29 AM
|$30.32 Million in Sales Expected for NanoString Technologies Inc (NSTG) This Quarter|
www.americanbankingnews.com - January 11 at 7:02 AM
| Brokerages Anticipate NanoString Technologies Inc (NSTG) Will Announce Earnings of -$0.48 Per Share|
www.americanbankingnews.com - January 9 at 11:34 AM
|NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017|
finance.yahoo.com - January 8 at 9:48 AM
|NanoString Technologies (NSTG) Stock Rating Upgraded by Zacks Investment Research|
www.americanbankingnews.com - January 3 at 1:20 PM
|NanoString Technologies, Inc. :NSTG-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018|
finance.yahoo.com - January 1 at 9:24 AM
|Head to Head Review: NanoString Technologies (NSTG) vs. IRIS International (IRIS)|
www.americanbankingnews.com - December 29 at 1:18 PM
|ETFs with exposure to NanoString Technologies, Inc. : December 28, 2017|
finance.yahoo.com - December 28 at 4:46 PM
|NanoString Technologies Inc (NSTG) Given Consensus Rating of "Hold" by Analysts|
www.americanbankingnews.com - December 26 at 9:52 AM
|NanoString Technologies Inc (NSTG) Expected to Announce Earnings of -$0.48 Per Share|
www.americanbankingnews.com - December 24 at 1:08 AM
|Analyzing IRIS International (IRIS) and NanoString Technologies (NSTG)|
www.americanbankingnews.com - December 22 at 1:18 AM
|NanoString Technologies Inc (NASDAQ:NSTG): Should The Recent EPS Drop Worry You?|
finance.yahoo.com - December 19 at 5:21 PM
|NanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of Hematology|
finance.yahoo.com - December 17 at 9:28 AM
|IRIS International (IRIS) versus NanoString Technologies (NSTG) Head-To-Head Survey|
www.americanbankingnews.com - December 15 at 11:08 AM
|$30.19 Million in Sales Expected for NanoString Technologies, Inc. (NSTG) This Quarter|
www.americanbankingnews.com - December 8 at 12:06 PM
| Brokerages Expect NanoString Technologies, Inc. (NSTG) Will Post Earnings of -$0.48 Per Share|
www.americanbankingnews.com - December 6 at 8:04 AM
|NanoString Technologies, Inc. (NSTG) Given Consensus Recommendation of "Hold" by Analysts|
www.americanbankingnews.com - December 1 at 3:52 PM
|Head to Head Analysis: IRIS International (IRIS) vs. NanoString Technologies (NSTG)|
www.americanbankingnews.com - December 1 at 7:59 AM
|NanoString Highlights Record Number of nCounter-Based Research Abstracts at the 2017 Annual Meeting of the Society of Immunotherapy of Cancer (SITC)|
finance.yahoo.com - November 28 at 5:22 PM
|NanoString Technologies, Inc. (NSTG) Expected to Post Quarterly Sales of $30.19 Million|
www.americanbankingnews.com - November 20 at 11:04 AM
| Brokerages Expect NanoString Technologies, Inc. (NSTG) to Post -$0.48 EPS|
www.americanbankingnews.com - November 18 at 1:32 PM
|NanoString Technologies, Inc. (NSTG) Receives Consensus Recommendation of "Hold" from Brokerages|
www.americanbankingnews.com - November 6 at 10:34 AM
|NanoString Technologies, Inc. (NSTG) Price Target Lowered to $12.00 at Robert W. Baird|
www.americanbankingnews.com - November 5 at 8:22 AM
|NanoString Technologies, Inc. to Host Earnings Call|
finance.yahoo.com - November 4 at 8:13 AM
NanoString Technologies (NASDAQ:NSTG) SEC Filings
This page is loading this company's SEC Filings. Please wait...
NanoString Technologies (NASDAQ:NSTG) Income Statement, Balance Sheet and Cash Flow Statement
NanoString Technologies (NASDAQ NSTG) Stock Chart for Saturday, March, 24, 2018